Status:
COMPLETED
The Experiences of People Prescribed Opioid Pain Medicines
Lead Sponsor:
University of Nottingham
Collaborating Sponsors:
Boots UK
National Institute for Health Research, United Kingdom
Conditions:
Pain
Opioid Use
Eligibility:
All Genders
18+ years
Brief Summary
Opioids are morphine-type medicines which come from the opium poppy or are similar-to morphine. They are very effective for short-term pain, cancer pain, and pain at the end of life. Opioids are thoug...
Eligibility Criteria
Inclusion
- Ability to give informed consent
- Adults aged 18 years and above, with no upper age limit
- Prescribed any opioid analgesic (defined as any opioid or opioid/paracetamol combination analgesic from sections 4.7.2 and 4.7.1 British National Formulary) for non-cancer pain for a period of ≥3 months (defined as ≥ 2 opioid prescriptions issued in the previous 3 months with a minimum interval of 60 days between the first and last prescription)
Exclusion
- Cancer pain
- Terminal illness
- Vulnerable patients (e.g. severe mental illness, learning difficulties, dementia, care home residents)
- Unable to understand English
- Deemed by their GP to be inappropriate to contact
Key Trial Info
Start Date :
October 19 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2022
Estimated Enrollment :
619 Patients enrolled
Trial Details
Trial ID
NCT04888897
Start Date
October 19 2021
End Date
December 1 2022
Last Update
December 21 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Nottingham
Nottingham, United Kingdom, NG7 2RD